Literature DB >> 26048250

Fatal Coxsackie meningoencephalitis in a patient with B-cell lymphopenia and hypogammaglobulinemia following rituximab therapy.

Thamiris Palacios1, Luther Bartelt2, William Scheld2, M Beatriz Lopes3, Sarah M Kelting3, Steven Holland4, W Ian Lipkin5, Phenix-Lan Quan5, Larry Borish6, Monica Lawrence7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26048250      PMCID： PMC4608550          DOI： 10.1016/j.anai.2015.05.007

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN： 1081-1206            Impact factor:   6.347


× No keyword cloud information.
  10 in total

1.  Common variable immunodeficiency: clinical and immunological features of 248 patients.

Authors:  C Cunningham-Rundles; C Bodian
Journal:  Clin Immunol       Date:  1999-07       Impact factor: 3.969

2.  Enteroviral meningoencephalitis in X-linked agammaglobulinemia: intensive immunoglobulin therapy and sequential viral detection in cerebrospinal fluid by polymerase chain reaction.

Authors:  P Quartier; S Foray; J L Casanova; I Hau-Rainsard; S Blanche; A Fischer
Journal:  Pediatr Infect Dis J       Date:  2000-11       Impact factor: 2.129

Review 3.  Management of Evans syndrome.

Authors:  Alice Norton; Irene Roberts
Journal:  Br J Haematol       Date:  2006-01       Impact factor: 6.998

4.  Enterovirus meningitis in adults.

Authors:  H A Rotbart; P J Brennan; K H Fife; J R Romero; J A Griffin; M A McKinlay; F G Hayden
Journal:  Clin Infect Dis       Date:  1998-10       Impact factor: 9.079

5.  Effect of rituximab on human in vivo antibody immune responses.

Authors:  Mark D Pescovitz; Troy R Torgerson; Hans D Ochs; Elizabeth Ocheltree; Paula McGee; Heidi Krause-Steinrauf; John M Lachin; Jennifer Canniff; Carla Greenbaum; Kevan C Herold; Jay S Skyler; Adriana Weinberg
Journal:  J Allergy Clin Immunol       Date:  2011-09-09       Impact factor: 10.793

6.  Hypogammaglobulinaemia after rituximab treatment-incidence and outcomes.

Authors:  M Makatsori; S Kiani-Alikhan; A L Manson; N Verma; M Leandro; N P Gurugama; H J Longhurst; S Grigoriadou; M Buckland; E Kanfer; S Hanson; M A A Ibrahim; B Grimbacher; R Chee; S L Seneviratne
Journal:  QJM       Date:  2014-04-28

7.  High susceptibility for enterovirus infection and virus excretion features in Tunisian patients with primary immunodeficiencies.

Authors:  Nadia Driss; Imen Ben-Mustapha; Fethi Mellouli; Ahlem Ben Yahia; Henda Touzi; Mohamed Bejaoui; Mohamed Ben Ghorbel; Henda Triki; Mohamed-Ridha Barbouche
Journal:  Clin Vaccine Immunol       Date:  2012-08-22

Review 8.  Tissue tropism, pathology and pathogenesis of enterovirus infection.

Authors:  Atis Muehlenbachs; Julu Bhatnagar; Sherif R Zaki
Journal:  J Pathol       Date:  2015-01       Impact factor: 7.996

Review 9.  Chronic enteroviral meningoencephalitis in agammaglobulinemic patients.

Authors:  R E McKinney; S L Katz; C M Wilfert
Journal:  Rev Infect Dis       Date:  1987 Mar-Apr

10.  Fatal case of enterovirus 71 infection and rituximab therapy, france, 2012.

Authors:  Somar Kassab; Tahar Saghi; Alexandre Boyer; Marie-Edith Lafon; Didier Gruson; Bruno Lina; Hervé Fleury; Isabelle Schuffenecker
Journal:  Emerg Infect Dis       Date:  2013-08       Impact factor: 6.883
  10 in total
  5 in total

1.  Enteroviral T-cell encephalitis related to immunosuppressive therapy including rituximab.

Authors:  Nicolas Garzo-Caldas; Elena Ruiz-Sainz; Sara Vila-Bedmar; Sara Llamas-Velasco; Aurelio Hernández-Lain; Juan Ruiz-Morales; Dolores Folgueira-López; Alberto Villarejo-Galende
Journal:  Neurology       Date:  2017-06-23       Impact factor: 9.910

Review 2.  Emerging Infections and Pertinent Infections Related to Travel for Patients with Primary Immunodeficiencies.

Authors:  Kathleen E Sullivan; Hamid Bassiri; Ahmed A Bousfiha; Beatriz T Costa-Carvalho; Alexandra F Freeman; David Hagin; Yu L Lau; Michail S Lionakis; Ileana Moreira; Jorge A Pinto; M Isabel de Moraes-Pinto; Amit Rawat; Shereen M Reda; Saul Oswaldo Lugo Reyes; Mikko Seppänen; Mimi L K Tang
Journal:  J Clin Immunol       Date:  2017-08-07       Impact factor: 8.317

3.  Fatal Enteroviral Encephalitis in a Patient with Common Variable Immunodeficiency Harbouring a Novel Mutation in NFKB2.

Authors:  Charlotte A Slade; Catriona McLean; Thomas Scerri; Tran Binh Giang; Steven Megaloudis; Alexander Strathmore; Jessica C Tempany; Katherine Nicholls; Colleen D'Arcy; Melanie Bahlo; Philip D Hodgkin; Jo A Douglass; Vanessa L Bryant
Journal:  J Clin Immunol       Date:  2019-03-29       Impact factor: 8.542

4.  Chronic enteroviral meningoencephalitis in a patient on rituximab for the treatment of psoriatic arthritis: A case report and brief literature review.

Authors:  Roberto Tellez; Allison M Lastinger; Jeffery P Hogg
Journal:  IDCases       Date:  2019-05-09

5.  Iatrogenic antibody deficiency from B-cell targeted therapies in autoimmune rheumatic diseases.

Authors:  Sonali Wijetilleka; David Jayne; Chetan Mukhtyar; Mohammed Yousuf Karim
Journal:  Lupus Sci Med       Date:  2019-07-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.